Michael J. Embler
Michael J. Embler's purchase track record
Michael J. Embler has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 6/3/2026 | VTR | $197K | +17.2% | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
NMI Holdings (NMIH) sees rising option volatility and JPMorgan target cut. Implied volatility for NMI Holdings stock options has surged recently, indicating heightened market uncertainty. At the same time, JP Morgan maintained an Overweight rating but lowered its price target to $45. This move comes as the stock trades near its 52-week low, with the new target sitting below the current average analyst estimate of $49.86.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Analysts Lower AAL Fair Value Amid Rising Fuel Cost Concerns. Analysts have lowered American Airlines’ fair value after reexamining fuel cost assumptions. The recent Goldman Sachs cut to an $11 target reflects the same concern. New regulatory pressure to carry epinephrine on all flights could add to operating costs, while broader airline earnings reports from Delta give context to the sector’s mixed outlook.
Transaction History
| VTR | ▲ Buy | Grant | 72 | $7K | 7/16/2026 | View on chart |
| VTR | ▲ Buy | Open Market | 2,500 | $197K | 6/3/2026 | View on chart |
| NMIH | ▲ Buy | Grant | 4,512 | $0 | 5/14/2026 | View on chart |
| VTR | ▲ Buy | Grant | 2,047 | $185K | 5/13/2026 | View on chart |
| VTR | ▲ Buy | Grant | 67 | $6K | 4/16/2026 | View on chart |
| VTR | ▲ Buy | Grant | 68 | $5K | 1/15/2026 | View on chart |
| NMIH | ▼ Sell | Open Market | 20,000 | $738K | 11/19/2025 | View on chart |
| VTR | ▲ Buy | Grant | 75 | $5K | 10/16/2025 | View on chart |
| VTR | ▲ Buy | Grant | 79 | $5K | 7/17/2025 | View on chart |
| VTR | ▲ Buy | Grant | 2,882 | $185K | 5/13/2025 | View on chart |
| NMIH | ▲ Buy | Grant | 4,439 | $0 | 5/8/2025 | View on chart |
| VTR | ▲ Buy | Grant | 55 | $4K | 4/17/2025 | View on chart |
| VTR | ▲ Buy | Grant | 60 | $3K | 1/16/2025 | View on chart |
| VTR | ▲ Buy | Grant | 54 | $3K | 10/17/2024 | View on chart |
| NMIH | ▼ Sell | Open Market | 26,008 | $1.0M | 7/31/2024 | View on chart |
| NMIH | ▼ Sell | Gift | 9,031 | $0 | 7/31/2024 | View on chart |
| VTR | ▲ Buy | Grant | 65 | $3K | 7/18/2024 | View on chart |
| AAL | ▲ Buy | Grant | 12,908 | $0 | 6/5/2024 | View on chart |
| VTR | ▲ Buy | Grant | 3,648 | $175K | 5/14/2024 | View on chart |
| NMIH | ▲ Buy | Grant | 4,166 | $0 | 5/9/2024 | View on chart |
| VTR | ▲ Buy | Grant | 42 | $2K | 4/18/2024 | View on chart |
| VTR | ▲ Buy | Grant | 37 | $2K | 1/18/2024 | View on chart |
| VTR | ▲ Buy | Grant | 41 | $2K | 10/12/2023 | View on chart |
| VTR | ▲ Buy | Grant | 36 | $2K | 7/13/2023 | View on chart |
| VTR | ▲ Buy | Grant | 3,835 | $175K | 5/16/2023 | View on chart |
| NMIH | ▲ Buy | Grant | 5,847 | $0 | 5/11/2023 | View on chart |
| AAL | ▲ Buy | Grant | 10,460 | $0 | 5/10/2023 | View on chart |
| AAL | ▲ Buy | Grant | 9,287 | $0 | 6/8/2022 | View on chart |
| NMIH | ▲ Buy | Grant | 6,940 | $0 | 5/12/2022 | View on chart |
| VTR | ▲ Buy | Grant | 3,056 | $175K | 4/27/2022 | View on chart |
| VTR | ▲ Buy | Grant | 557 | $31K | 3/7/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Ventas Expands Acquisition Budget to $3B, Targets 17% NOI Growth
Ventas announced it will increase its acquisition budget to $3 billion and aims for up to 17 % growth in net operating income. Barclays cut its price target to $91, citing the higher budget and the company’s strong dividend payout of over 370 % of earnings. The firm is also noted for its role in the senior‑housing shortfall, a sector that has helped REITs rebound from recent declines. Current technicals show the stock near its 200‑day moving‑average and a support level at $86.74.
Ventas Expands Acquisition Budget to $3B, Targets 17% NOI Growth. Ventas announced it will increase its acquisition budget to $3 billion and aims for up to 17 % growth in net operating income. Barclays cut its price target to $91, citing the higher budget and the company’s strong dividend payout of over 370 % of earnings. The firm is also noted for its role in the senior‑housing shortfall, a sector that has helped REITs rebound from recent declines. Current technicals show the stock near its 200‑day moving‑average and a support level at $86.74.